28 results on '"Ávila-Nieto, Carlos"'
Search Results
2. Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models
3. An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
4. Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
5. Detection of SARS-CoV-2 in a cat owned by a COVID-19–affected patient in Spain
6. Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant
7. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
8. Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 and golden Syrian hamster upon SARS-CoV-2 infection.
9. The first year of young group of the Spanish Immunology Society: Progress, challenges, and next steps
10. Syphilis vaccine: challenges, controversies and opportunities
11. Comparison of Reverse Transcription (RT)-Quantitative PCR and RT-Droplet Digital PCR for Detection of Genomic and Subgenomic SARS-CoV-2 RNA
12. Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
13. Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals
14. Limited immune responses after three months of BNT162b2 vaccine in SARS-CoV-2 uninfected elders living in long-term care facilities
15. SARS-CoV-2 B.1.351 (beta) variant shows enhanced infectivity in K18-hACE2 transgenic mice and expanded tropism to wildtype mice compared to B.1 variant
16. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
17. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients
18. Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
19. Piglets inoculated by different routes are not susceptible to SARS‐CoV‐2, but those inoculated parenterally were immunized against the virus
20. Piglets inoculated by different routes are not susceptible to SARS-CoV-2, but those inoculated parenterally were immunized against the virus
21. Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies
22. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in hamsters
23. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
24. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
25. Stable neutralizing antibody levels six months after mild and severe COVID-19 episode
26. Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies
27. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
28. Pigs are not susceptible to SARS‐CoV‐2 infection but are a model for viral immunogenicity studies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.